Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.

Martin S. Hirsch; Françoise Brun-Vézinet; Bonaventura Clotet; Brian Conway; Daniel R. Kuritzkes; Richard T. D'Aquila; Lisa M. Demeter; Scott M. Hammer; Victoria A. Johnson; Clive Loveday; John W. Mellors; Douglas D. Richman

Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.

Martin S. Hirsch^*, Françoise Brun-Vézinet, Bonaventura Clotet, Brian Conway, Daniel R. Kuritzkes, Richard T. D'Aquila, Lisa M. Demeter, Scott M. Hammer, Victoria A. Johnson, Clive Loveday, John W. Mellors, Douglas D. Richman

^*Corresponding author for this work

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

In 1996 the International AIDS Society-USA convened an international panel of experts in HIV drug resistance and clinical management to develop guidelines for the clinical use and limitations of resistance testing. Since then the International AIDS Society-USA Resistance Testing Guidelines Panel has developed and regularly published its recommendations. The latest panel recommendations appear in the July 1 issue of Clinical Infectious Diseases. We periodically pose questions to the panel relating to clinical elements of resistance testing that have been collected from HIV practitioners across the nation. We are happy to feature the latest edition in this issue of Topics in HIV Medicine. It is our hope that addressing these issues will help guide your treatment strategy decisions regarding resistance testing.

Original language	English (US)
Pages (from-to)	150-154
Number of pages	5
Journal	Topics in HIV medicine : a publication of the International AIDS Society, USA
Volume	11
Issue number	4
State	Published - Jan 1 2003

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Hirsch, M. S., Brun-Vézinet, F., Clotet, B., Conway, B., Kuritzkes, D. R., D'Aquila, R. T., Demeter, L. M., Hammer, S. M., Johnson, V. A., Loveday, C., Mellors, J. W., & Richman, D. D. (2003). Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel. Topics in HIV medicine : a publication of the International AIDS Society, USA, 11(4), 150-154.

Hirsch, Martin S. ; Brun-Vézinet, Françoise ; Clotet, Bonaventura ; Conway, Brian ; Kuritzkes, Daniel R. ; D'Aquila, Richard T. ; Demeter, Lisa M. ; Hammer, Scott M. ; Johnson, Victoria A. ; Loveday, Clive ; Mellors, John W. ; Richman, Douglas D. / Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel. In: Topics in HIV medicine : a publication of the International AIDS Society, USA. 2003 ; Vol. 11, No. 4. pp. 150-154.

@article{ce97de99257341c8979a457338db486a,

title = "Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.",

abstract = "In 1996 the International AIDS Society-USA convened an international panel of experts in HIV drug resistance and clinical management to develop guidelines for the clinical use and limitations of resistance testing. Since then the International AIDS Society-USA Resistance Testing Guidelines Panel has developed and regularly published its recommendations. The latest panel recommendations appear in the July 1 issue of Clinical Infectious Diseases. We periodically pose questions to the panel relating to clinical elements of resistance testing that have been collected from HIV practitioners across the nation. We are happy to feature the latest edition in this issue of Topics in HIV Medicine. It is our hope that addressing these issues will help guide your treatment strategy decisions regarding resistance testing.",

author = "Hirsch, {Martin S.} and Fran{\c c}oise Brun-V{\'e}zinet and Bonaventura Clotet and Brian Conway and Kuritzkes, {Daniel R.} and D'Aquila, {Richard T.} and Demeter, {Lisa M.} and Hammer, {Scott M.} and Johnson, {Victoria A.} and Clive Loveday and Mellors, {John W.} and Richman, {Douglas D.}",

year = "2003",

month = jan,

day = "1",

language = "English (US)",

volume = "11",

pages = "150--154",

journal = "Topics in antiviral medicine",

issn = "2161-5861",

publisher = "International Antiviral Society",

number = "4",

}

Hirsch, MS, Brun-Vézinet, F, Clotet, B, Conway, B, Kuritzkes, DR, D'Aquila, RT, Demeter, LM, Hammer, SM, Johnson, VA, Loveday, C, Mellors, JW & Richman, DD 2003, 'Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.', Topics in HIV medicine : a publication of the International AIDS Society, USA, vol. 11, no. 4, pp. 150-154.

Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel. / Hirsch, Martin S.; Brun-Vézinet, Françoise; Clotet, Bonaventura; Conway, Brian; Kuritzkes, Daniel R.; D'Aquila, Richard T.; Demeter, Lisa M.; Hammer, Scott M.; Johnson, Victoria A.; Loveday, Clive; Mellors, John W.; Richman, Douglas D.

In: Topics in HIV medicine : a publication of the International AIDS Society, USA, Vol. 11, No. 4, 01.01.2003, p. 150-154.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.

AU - Hirsch, Martin S.

AU - Brun-Vézinet, Françoise

AU - Clotet, Bonaventura

AU - Conway, Brian

AU - Kuritzkes, Daniel R.

AU - D'Aquila, Richard T.

AU - Demeter, Lisa M.

AU - Hammer, Scott M.

AU - Johnson, Victoria A.

AU - Loveday, Clive

AU - Mellors, John W.

AU - Richman, Douglas D.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - In 1996 the International AIDS Society-USA convened an international panel of experts in HIV drug resistance and clinical management to develop guidelines for the clinical use and limitations of resistance testing. Since then the International AIDS Society-USA Resistance Testing Guidelines Panel has developed and regularly published its recommendations. The latest panel recommendations appear in the July 1 issue of Clinical Infectious Diseases. We periodically pose questions to the panel relating to clinical elements of resistance testing that have been collected from HIV practitioners across the nation. We are happy to feature the latest edition in this issue of Topics in HIV Medicine. It is our hope that addressing these issues will help guide your treatment strategy decisions regarding resistance testing.

AB - In 1996 the International AIDS Society-USA convened an international panel of experts in HIV drug resistance and clinical management to develop guidelines for the clinical use and limitations of resistance testing. Since then the International AIDS Society-USA Resistance Testing Guidelines Panel has developed and regularly published its recommendations. The latest panel recommendations appear in the July 1 issue of Clinical Infectious Diseases. We periodically pose questions to the panel relating to clinical elements of resistance testing that have been collected from HIV practitioners across the nation. We are happy to feature the latest edition in this issue of Topics in HIV Medicine. It is our hope that addressing these issues will help guide your treatment strategy decisions regarding resistance testing.

UR - http://www.scopus.com/inward/record.url?scp=0141671683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141671683&partnerID=8YFLogxK

M3 - Article

C2 - 12876334

AN - SCOPUS:0141671683

VL - 11

SP - 150

EP - 154

JO - Topics in antiviral medicine

JF - Topics in antiviral medicine

SN - 2161-5861

IS - 4

ER -

Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this